Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer

Abstract Background Breast cancer is a disease in which cell grows rapidly forming a mass in the breast. HER2 polymorphisms Ile655Val have been studied as biomarkers for breast cancer and may comprise a risk factor of cardiac toxicity for breast cancer-consuming trastuzumab. Aim of work: In this stu...

Full description

Bibliographic Details
Main Authors: Desriani, Azamris, Shabrina S. Ghaissani, Senja R. Kinanti, Muhammad A. Warisman, N. Fitria
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Journal of Genetic Engineering and Biotechnology
Subjects:
Online Access:https://doi.org/10.1186/s43141-020-00108-9
_version_ 1797204409680134144
author Desriani
Azamris
Shabrina S. Ghaissani
Senja R. Kinanti
Muhammad A. Warisman
N. Fitria
author_facet Desriani
Azamris
Shabrina S. Ghaissani
Senja R. Kinanti
Muhammad A. Warisman
N. Fitria
author_sort Desriani
collection DOAJ
description Abstract Background Breast cancer is a disease in which cell grows rapidly forming a mass in the breast. HER2 polymorphisms Ile655Val have been studied as biomarkers for breast cancer and may comprise a risk factor of cardiac toxicity for breast cancer-consuming trastuzumab. Aim of work: In this study, we developed a simple, low cost, and rapid test to detect polymorphism at HER2 gene using SYBR Green I-based melting curve method. Subjects and methods In this report, we performed allelic discrimination with real-time temperature melting (Tm) Shift SYBR Green I-based melting curve method. The melting profiles of amplified DNA HER-2 Ile655Val and its characteristics were analyzed. Result Tm value of HER2 GG and AA alleles were 85 ± 0.14 °C and 82.5 ± 0.23 °C, respectively, while cycle threshold (Ct) value of GG, AG, and AA alleles were 19.6 ± 0.27, 22.5 ± 0.23, 18.6 ± 0.22 correspondingly; furthermore, no template control has shown consisting Ct value at 31.18 ± 0.27. The developed methods’ characteristics were optimum annealing at 62 °C and Kappa coefficient value 1 with the mean almost consistent with PCR-sequencing. The coefficient of variability for intra-assay of GG, AG, and AA was in the range of 0.2–1%, while the coefficient of variability for inter-assay for each were in the range 0.7–1%. Further, based on PCR, shelf-life assay has shown stability for 3 months of storage observation. Conclusion This approach may be considered as simple, rapid, and low cost supporting the rapid study of HER2 epidemiology. Furthermore, the developed methods potentially facilitate clinicians in dealing with breast cancer patients, especially in considering about the cardiotoxicity effect of trastuzumab.
first_indexed 2024-04-24T08:34:46Z
format Article
id doaj.art-a885e55abd16412b88d6bc796143dc18
institution Directory Open Access Journal
issn 2090-5920
language English
last_indexed 2024-04-24T08:34:46Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Journal of Genetic Engineering and Biotechnology
spelling doaj.art-a885e55abd16412b88d6bc796143dc182024-04-16T17:55:45ZengElsevierJournal of Genetic Engineering and Biotechnology2090-59202021-01-011911710.1186/s43141-020-00108-9Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancerDesriani0Azamris1Shabrina S. Ghaissani2Senja R. Kinanti3Muhammad A. Warisman4N. Fitria5Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI)Division of Surgical Oncology Medical School of M. Djamil Hospital, Andalas UniversityResearch Center for Biotechnology, Indonesian Institute of Sciences (LIPI)Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI)Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI)Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas UniversityAbstract Background Breast cancer is a disease in which cell grows rapidly forming a mass in the breast. HER2 polymorphisms Ile655Val have been studied as biomarkers for breast cancer and may comprise a risk factor of cardiac toxicity for breast cancer-consuming trastuzumab. Aim of work: In this study, we developed a simple, low cost, and rapid test to detect polymorphism at HER2 gene using SYBR Green I-based melting curve method. Subjects and methods In this report, we performed allelic discrimination with real-time temperature melting (Tm) Shift SYBR Green I-based melting curve method. The melting profiles of amplified DNA HER-2 Ile655Val and its characteristics were analyzed. Result Tm value of HER2 GG and AA alleles were 85 ± 0.14 °C and 82.5 ± 0.23 °C, respectively, while cycle threshold (Ct) value of GG, AG, and AA alleles were 19.6 ± 0.27, 22.5 ± 0.23, 18.6 ± 0.22 correspondingly; furthermore, no template control has shown consisting Ct value at 31.18 ± 0.27. The developed methods’ characteristics were optimum annealing at 62 °C and Kappa coefficient value 1 with the mean almost consistent with PCR-sequencing. The coefficient of variability for intra-assay of GG, AG, and AA was in the range of 0.2–1%, while the coefficient of variability for inter-assay for each were in the range 0.7–1%. Further, based on PCR, shelf-life assay has shown stability for 3 months of storage observation. Conclusion This approach may be considered as simple, rapid, and low cost supporting the rapid study of HER2 epidemiology. Furthermore, the developed methods potentially facilitate clinicians in dealing with breast cancer patients, especially in considering about the cardiotoxicity effect of trastuzumab.https://doi.org/10.1186/s43141-020-00108-9Tm Shift SYBR Green IqPCR assayHER-2 Ile655Val DetectionBreast cancerTrastuzumab
spellingShingle Desriani
Azamris
Shabrina S. Ghaissani
Senja R. Kinanti
Muhammad A. Warisman
N. Fitria
Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
Journal of Genetic Engineering and Biotechnology
Tm Shift SYBR Green I
qPCR assay
HER-2 Ile655Val Detection
Breast cancer
Trastuzumab
title Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
title_full Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
title_fullStr Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
title_full_unstemmed Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
title_short Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
title_sort design and characterization of a sybr green i based melting curve method for investigation of her2i655v polymorphism in breast cancer
topic Tm Shift SYBR Green I
qPCR assay
HER-2 Ile655Val Detection
Breast cancer
Trastuzumab
url https://doi.org/10.1186/s43141-020-00108-9
work_keys_str_mv AT desriani designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer
AT azamris designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer
AT shabrinasghaissani designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer
AT senjarkinanti designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer
AT muhammadawarisman designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer
AT nfitria designandcharacterizationofasybrgreenibasedmeltingcurvemethodforinvestigationofher2i655vpolymorphisminbreastcancer